West Pharmaceutical Services Net Income
| WST Stock | USD 231.62 5.43 2.29% |
As of the 5th of February, West Pharmaceutical maintains the Market Risk Adjusted Performance of (0.19), mean deviation of 1.51, and Standard Deviation of 2.02. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of West Pharmaceutical Services, as well as the relationship between them.
West Pharmaceutical Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 5.5414 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 566.6 M | 594.9 M | |
| Net Income Applicable To Common Shares | 566.6 M | 594.9 M | |
| Net Income From Continuing Ops | 566.6 M | 283.5 M | |
| Net Income Per Share | 6.07 | 6.38 | |
| Net Income Per E B T | 0.74 | 0.58 |
West | Net Income | Build AI portfolio with West Stock |
The evolution of Net Income for West Pharmaceutical Services provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how West Pharmaceutical compares to historical norms and industry peers.
Latest West Pharmaceutical's Net Income Growth Pattern
Below is the plot of the Net Income of West Pharmaceutical Services over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in West Pharmaceutical financial statement analysis. It represents the amount of money remaining after all of West Pharmaceutical Services operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is West Pharmaceutical's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in West Pharmaceutical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 492.7 M | 10 Years Trend |
|
Net Income |
| Timeline |
West Net Income Regression Statistics
| Arithmetic Mean | 299,449,426 | |
| Geometric Mean | 203,669,924 | |
| Coefficient Of Variation | 76.58 | |
| Mean Deviation | 205,340,502 | |
| Median | 206,900,000 | |
| Standard Deviation | 229,331,905 | |
| Sample Variance | 52593.1T | |
| Range | 646.8M | |
| R-Value | 0.92 | |
| Mean Square Error | 8962T | |
| R-Squared | 0.84 | |
| Slope | 41,629,208 | |
| Total Sum of Squares | 841490T |
West Net Income History
Other Fundumenentals of West Pharmaceutical
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
West Pharmaceutical Net Income component correlations
West Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for West Pharmaceutical is extremely important. It helps to project a fair market value of West Stock properly, considering its historical fundamentals such as Net Income. Since West Pharmaceutical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of West Pharmaceutical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of West Pharmaceutical's interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Health Care Equipment & Supplies market expansion? Will West introduce new products? Factors like these will boost the valuation of West Pharmaceutical. Anticipated expansion of West directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about West Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.038 | Dividend Share 0.84 | Earnings Share 6.6 | Revenue Per Share | Quarterly Revenue Growth 0.077 |
Investors evaluate West Pharmaceutical using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating West Pharmaceutical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause West Pharmaceutical's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between West Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if West Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, West Pharmaceutical's market price signifies the transaction level at which participants voluntarily complete trades.
West Pharmaceutical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to West Pharmaceutical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of West Pharmaceutical.
| 11/07/2025 |
| 02/05/2026 |
If you would invest 0.00 in West Pharmaceutical on November 7, 2025 and sell it all today you would earn a total of 0.00 from holding West Pharmaceutical Services or generate 0.0% return on investment in West Pharmaceutical over 90 days. West Pharmaceutical is related to or competes with Waters, Quest Diagnostics, Hologic, Zimmer Biomet, Illumina, Laboratory, and Medpace Holdings. West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drug... More
West Pharmaceutical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure West Pharmaceutical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess West Pharmaceutical Services upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 12.18 | |||
| Value At Risk | (3.58) | |||
| Potential Upside | 2.64 |
West Pharmaceutical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for West Pharmaceutical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as West Pharmaceutical's standard deviation. In reality, there are many statistical measures that can use West Pharmaceutical historical prices to predict the future West Pharmaceutical's volatility.| Risk Adjusted Performance | (0.1) | |||
| Jensen Alpha | (0.34) | |||
| Total Risk Alpha | (0.38) | |||
| Treynor Ratio | (0.20) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of West Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
West Pharmaceutical February 5, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.1) | |||
| Market Risk Adjusted Performance | (0.19) | |||
| Mean Deviation | 1.51 | |||
| Coefficient Of Variation | (732.84) | |||
| Standard Deviation | 2.02 | |||
| Variance | 4.07 | |||
| Information Ratio | (0.16) | |||
| Jensen Alpha | (0.34) | |||
| Total Risk Alpha | (0.38) | |||
| Treynor Ratio | (0.20) | |||
| Maximum Drawdown | 12.18 | |||
| Value At Risk | (3.58) | |||
| Potential Upside | 2.64 | |||
| Skewness | (0.29) | |||
| Kurtosis | 1.52 |
West Pharmaceutical Backtested Returns
West Pharmaceutical shows Sharpe Ratio of -0.12, which attests that the company had a -0.12 % return per unit of risk over the last 3 months. West Pharmaceutical exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out West Pharmaceutical's Mean Deviation of 1.51, standard deviation of 2.02, and Market Risk Adjusted Performance of (0.19) to validate the risk estimate we provide. The firm maintains a market beta of 1.45, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, West Pharmaceutical will likely underperform. At this point, West Pharmaceutical has a negative expected return of -0.23%. Please make sure to check out West Pharmaceutical's maximum drawdown and rate of daily change , to decide if West Pharmaceutical performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.06 |
Very weak reverse predictability
West Pharmaceutical Services has very weak reverse predictability. Overlapping area represents the amount of predictability between West Pharmaceutical time series from 7th of November 2025 to 22nd of December 2025 and 22nd of December 2025 to 5th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of West Pharmaceutical price movement. The serial correlation of -0.06 indicates that barely 6.0% of current West Pharmaceutical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.06 | |
| Spearman Rank Test | -0.11 | |
| Residual Average | 0.0 | |
| Price Variance | 349.44 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
West Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, West Pharmaceutical Services reported net income of 492.7 M. This is 44.37% higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is 13.71% higher than that of the company.
West Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses West Pharmaceutical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of West Pharmaceutical could also be used in its relative valuation, which is a method of valuing West Pharmaceutical by comparing valuation metrics of similar companies.West Pharmaceutical is currently under evaluation in net income category among its peers.
West Pharmaceutical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, West Pharmaceutical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to West Pharmaceutical's managers, analysts, and investors.Environmental | Governance | Social |
West Pharmaceutical Institutional Holders
Institutional Holdings refers to the ownership stake in West Pharmaceutical that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of West Pharmaceutical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing West Pharmaceutical's value.| Shares | Franklin Resources Inc | 2025-06-30 | 1.1 M | Kayne Anderson Rudnick Investment Management Llc | 2025-06-30 | 1.1 M | Durable Capital Partners Lp | 2025-06-30 | 1 M | Ubs Asset Mgmt Americas Inc | 2025-06-30 | 1 M | Amvescap Plc. | 2025-06-30 | 959.5 K | Norges Bank | 2025-06-30 | 917.8 K | Findlay Park Partners Llp | 2025-06-30 | 816.6 K | Northern Trust Corp | 2025-06-30 | 749.9 K | Proshare Advisors Llc | 2025-06-30 | 738.4 K | Vanguard Group Inc | 2025-06-30 | 9.3 M | Blackrock Inc | 2025-06-30 | 6.6 M |
West Fundamentals
| Return On Equity | 0.17 | ||||
| Return On Asset | 0.1 | ||||
| Profit Margin | 0.16 % | ||||
| Operating Margin | 0.22 % | ||||
| Current Valuation | 16.72 B | ||||
| Shares Outstanding | 71.94 M | ||||
| Shares Owned By Insiders | 0.59 % | ||||
| Shares Owned By Institutions | 97.85 % | ||||
| Number Of Shares Shorted | 1.92 M | ||||
| Price To Earning | 40.71 X | ||||
| Price To Book | 5.59 X | ||||
| Price To Sales | 5.52 X | ||||
| Revenue | 2.89 B | ||||
| Gross Profit | 1.07 B | ||||
| EBITDA | 743.8 M | ||||
| Net Income | 492.7 M | ||||
| Cash And Equivalents | 484.6 M | ||||
| Cash Per Share | 9.85 X | ||||
| Total Debt | 305.3 M | ||||
| Debt To Equity | 0.12 % | ||||
| Current Ratio | 3.80 X | ||||
| Book Value Per Share | 42.44 X | ||||
| Cash Flow From Operations | 653.4 M | ||||
| Short Ratio | 2.80 X | ||||
| Earnings Per Share | 6.60 X | ||||
| Price To Earnings To Growth | 2.99 X | ||||
| Target Price | 340.71 | ||||
| Number Of Employees | 10.6 K | ||||
| Beta | 1.19 | ||||
| Market Capitalization | 16.66 B | ||||
| Total Asset | 3.64 B | ||||
| Retained Earnings | 3.96 B | ||||
| Working Capital | 987.7 M | ||||
| Current Asset | 673.7 M | ||||
| Current Liabilities | 314.3 M | ||||
| Annual Yield | 0 % | ||||
| Five Year Return | 0.36 % | ||||
| Net Asset | 3.64 B | ||||
| Last Dividend Paid | 0.84 |
About West Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze West Pharmaceutical Services's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of West Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of West Pharmaceutical Services based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for West Stock Analysis
When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.